三种肠道病毒D68株在无血清HEK293A悬浮培养中的增殖与免疫学特性
研究筛选出HEK293A细胞适合EV-D68增殖,用无血清悬浮培养系统生产EV-D68 TW2014(B3)株,并开发了尺寸排阻与阴离子交换色谱联用的纯化工艺。动物实验显示完整病毒颗粒诱导高中和抗体应答而空颗粒应答低;EV-D68 MO(B1)和KY(A2)株也可在33℃下于该系统中增殖。三种甲醛灭活EV-D68均诱导特异性中和应答并能中和近期流行株,但不交叉中和EV-A71;EV-D68与EV-A71联合接种可诱导针对两者的中和应答。
要点
- HEK293A无血清悬浮培养适合EV-D68增殖,可用于灭活疫苗候选株生产。
- 完整EV-D68颗粒诱导高中和抗体应答,空颗粒应答低,纯化完整颗粒推荐用于疫苗生产。
- EV-D68与EV-A71联合接种可诱导针对两者的中和应答,支持二价肠道病毒疫苗开发。
核心结论
- sfHEK293A悬浮培养生产的EV-D68颗粒可用于制备EV-D68疫苗候选株。
- 纯化完整EV-D68颗粒用于疫苗生产推荐用于诱导高特异性免疫应答。
- EV-D68与EV-A71联合接种有益于二价肠道病毒疫苗开发。
研究设计与样本
- 研究进行细胞系筛选,发现HEK293A适合EV-D68增殖。
- 用EV-D68 TW2014(B3)株在无血清HEK293A悬浮系统中开发生产流程。
- 通过超速离心分离空颗粒与完整病毒颗粒,并在动物研究中评估中和抗体应答。
- 开发尺寸排阻与阴离子交换色谱联用纯化EV-D68颗粒。
- EV-D68 MO(B1)和KY(A2)株在sfHEK293A系统中于较低33℃条件增殖。
主要发现
- 空与完整EV-D68颗粒在动物研究中分别诱导低与高中和抗体应答。
- EV-D68 MO(B1)和KY(A2)株可在sfHEK293A细胞系统中于33℃增殖。
- 三种甲醛灭活EV-D68诱导EV-D68特异性中和应答,并能中和近期流行株。
- 血清 assay 中三种灭活EV-D68未能交叉中和EV-A71。
- EV-D68与EV-A71联合接种诱导针对两者的中和应答。
临床怎么用
- 疫苗生产可优先采用sfHEK293A悬浮培养系统增殖EV-D68。
- 疫苗制备应纯化完整EV-D68颗粒以诱导高特异性中和免疫应答。
- 可考虑将EV-D68与EV-A71组合开发二价肠道病毒疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Enterovirus D68 (EV-D68) is an emerging pathogen that typically causes respiratory illness but can also lead to acute flaccid myelitis, which has been reported in several outbreaks worldwide. As EV-D68 has been found to be difficult to infect and proliferate in the standard Vero cells, a viable manufacturing process for the development of inactivated EV-D68 vaccine is urgently needed. We performed cell line screening and found that the HEK293A is a suitable host for EV-D68 propagation. The EV-D68 TW2014 (B3) strain was used to develop the EV-D68 production using a serum-free HEK293A (sfHEK293A) suspension system. Two major EV-D68 particles, the empty and full viral particles, were separated by ultracentrifugation and were found to induce low and high neutralizing antibody responses, respectively, in animal studies. To facilitate the mass production of vaccine, a combination of size-exclusion and anion-exchange chromatography was developed to purify EV-D68 particles. High quality, pure EV-D68 particles could be obtained by this simple procedure for vaccine production. Additionally, we found that the EV-D68 MO (B1) and KY (A2) strains could also be propagated in this sfHEK293A cell system, but at a lower 33 °C condition. These three formalin-inactivated EV-D68s were shown to induce EV-D68-specific neutralizing responses and also neutralize a recently circulating strain, but failed to cross-neutralize enterovirus A71 (EV-A71) in sera assay. The combination of EV-D68 and EV-A71 in one vaccination induced the neutralizing responses against both viruses. Our results showed that EV-D68 particles produced from the sfHEK293A suspension culture could be used to prepare EV-D68 vaccine candidates. Purifying the full EV-D68 particles for vaccine production is recommended for inducing a high, specific immune response. Combination of EV-D68 and EV-A71 is beneficial for the development of bivalent enterovirus vaccine.
引用
- Shen YS, Fang CY, Chan TT, et al. Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture. Vaccine. 2026. PMID: 42086005. doi:10.1016/j.vaccine.2026.128665
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。